Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock
NASDAQ · ARCT
16.03
Fundamentals
Market cap
$455.62M
Price / Earnings ratio
-5.2x
Price / Sales ratio
16.4x
Price / Book ratio
2.8x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Arcturus Therapeutics Holdings Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees106
CEOMr. Joseph E. Payne M.Sc.
IPO DateApr 16, 2020
HeadquartersSan Diego, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director | 1972 |
| Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary | 1979 |
| Mr. Joseph Roberts | Principal Accounting Officer & Controller | 1983 |
| Mr. Lance Kurata | Chief Legal Officer | — |
| Mr. Dennis M. Mulroy | Chief Financial Officer | 1955 |
| Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing | — |
| Ms. Natasha O. Bowman | Chief Human Resources Officer | — |
| Mr. Kevin T. Skol | Chief Business Officer | — |
| Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer | — |
| Dr. Ye Zhang | Chief Regulatory & Quality Assurance Officer | — |
Fundamentals
Valuation
Market cap$455.62M
Price-to-sales ratio16.39
Price-to-book value2.80
Price-earnings ratio-5.20
Return on Equity-37.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-3.33
Income Statement
Average volume1,497,293
EBITDA$-75.79M
1 year high (52w)$24.17
1 year low (52w)$5.50
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



